Myelofibrosis

Disease2 papers1 finding

Humans1

Associations

1

CALR

upin humans1

1 study

CALR is associated with myelofibrosis in humans.
Humanspost-ET progression in younger patientsn = 328
Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults · British journal of haematology · 4 Sep 2026

Trial sponsors

AbbVie
Company5 trialsPhase 3795 people
The Emmes Company
Company1 trialPhase 213 people
University of Birmingham
1 trialPhase 2400 people
City of Hope Medical Center
1 trialPhase 2216 people
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
1 trialPhase 262 people
University of Southern California
1 trialPhase 230 people
Universitaire Ziekenhuizen KU Leuven
1 trialPhase 217 people
M.D. Anderson Cancer Center
1 trialPhase 1/229 people

Latest

3

British Journal of HaematologyHumans5 Sep

Age as a core disease modifier: Distinct clinical, molecular and prognostic landscapes of essential thrombocythaemia in adolescents and young adults

European Journal of HaematologyHumans1 Sep

High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome

Frontiers in OncologyReview26 Aug

Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms

Neutrophil-to-lymphocyte ratio